| Title: | Clinical subgroup-stratified plasma proteomic signatures improve risk prediction for myocardial infarction: SCORE2-Pro |
| Journal: | Cardiovascular Diabetology |
| Published: | 2 Feb 2026 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/41629928/ |
| DOI: | https://doi.org/10.1186/s12933-025-03050-7 |
Publication 18394
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BackgroundMyocardial infarction (MI) remains a leading cause of global mortality, with risk varying substantially across demographic and clinical subgroups. Although SCORE2 is widely implemented for cardiovascular risk stratification, the extent to which clinical subgroup specific plasma proteomics can further refine personalized MI risk prediction remains uncertain.MethodsSCORE2-Pro, a clinical subgroup-stratified plasma proteome prediction model was built stratified by sex, age, smoking status, non-high-density lipoprotein (non-HDL) cholesterol, and systolic blood pressure. In 51,010 UK Biobank participants (aged 40-69 years; 54.9% female) without MI at baseline, 70% were used for model development, and the remaining 30% for an internal hold-out validation. We used light gradient boosting machine classifiers and Cox proportional hazards models to identify top-predictive protein combinations and stratification strategies for MI.ResultsThe SCORE2-Pro model revealed distinct and highly effective protein panels for each subgroup. Compared with the clinical model, SCORE2-Pro remarkably enhanced predictive performance across demographic and clinical subgroups. A 9-protein model in females improved AUC by + 0.061 (P = 1.51 × 10−3), with a net reclassification index (NRI) of + 0.125 (P = 2.69 × 10−6). Similarly, a 7-protein model for middle-aged subpopulation demonstrated an AUC improvement of + 0.036 (P = 0.033) with an NRI of + 0.127 (P = 8.09 × 10−11). Notably, in high-risk populations, SCORE2-Pro model significantly improved reclassification performance compared with the clinical model (NRI: + 0.121, P = 0.020).ConclusionsBy adopting a clinical subgroup stratification approach using factors derived from SCORE2, we identified subgroup-specific proteomic signatures for MI that considerably improve predictive accuracy and reclassification beyond traditional clinical models.</p>
19 Keywords
- Adult
- Aged
- Biomarkers
- Blood Proteins
- Decision Support Techniques
- Female
- Heart Disease Risk Factors
- Humans
- Male
- Middle Aged
- Myocardial Infarction
- Predictive Value of Tests
- Prognosis
- Proteomics
- Reproducibility of Results
- Risk Assessment
- Risk Factors
- Sex Factors
- United Kingdom
9 Authors
- Muye Tong
- Minchun Zhang
- Min Xu
- Zhiwen Cao
- Guang Ning
- Weiqing Wang
- Jiqiu Wang
- Qian Yang
- Jie Zheng
1 Application
| Application ID | Title |
|---|---|
| 104086 | Omics Harbour: a multi-ancestry causal atlas of plasma proteome on human phoneme |
Enabling scientific discoveries that improve human health